Perspectives
Published Editorials and Industry Updates
Welcome to Perspectives, our blog designed to keep members, oncology stakeholders, and anyone interested in enhancing the care experience for oncology patients informed on critical issues. You’ll hear from thought leaders and learn about the impact and benefits of medically integrated pharmacy, operational insights designed to support you in the day-to-day delivery of care, as well as timely industry issues facing oncology pharmacy professionals.
Enhanced Clarity for Bispecific Therapies: A Call to Action
February 12, 2025
NCODA Perspective: Bispecific antibodies have revolutionized the treatment of various hematologic and solid tumor malignancies. These therapies, which simultaneously target two antigens, have varied adverse event (AE) profiles that pose challenges in categorization and operational management. To address these issues, NCODA supports the National Comprehensive Cancer Network’s (NCCN) initiative to refine terminology for more precise […]
read more
Preserving Patient-Centric Oncology Care Amid Step Therapy Changes
February 6, 2025
NCODA Perspective: The Inflation Reduction Act of 2022 (IRA) is designed to enhance Medicare by expanding benefits, lowering drug costs, and aiming to improve the program’s long-term sustainability. Provisions within the IRA allow Medicare to negotiate prices with drug manufacturers for certain Medicare Part B and Part D medications to help lower prescription drug costs […]
read more
The Pain of Pain: Navigating the Regulatory Landscape of Cancer Pain Management
January 3, 2025
Author: Natasha Olson, PharmD, NCODA Senior Manager of Clinical Communications & Outreach Healthcare providers treating cancer patients must navigate an intricate network of regulatory requirements and clinical guidelines to manage pain effectively. While opioids are a primary method for addressing cancer-related pain, the ongoing opioid epidemic has driven substantial regulatory changes, resulting in more stringent controls and […]
read more
Virginia Cancer Specialists Earns Full Accreditation from NCODA’s Center of Excellence Medically Integrated Pharmacy Program
December 5, 2024
Congratulations to NCODA member practice Virginia Cancer Specialists on their recent Center of Excellence MIP Accreditation! Virginia Cancer Specialists’ full accreditation offers a win-win for patients as well as practices, providers, employers, payers, and pharmaceutical companies, as it facilitates faster access of oncolytics to patients, improvement in medical adherence, reduced waste due to cost avoidance, […]
read more
Unlocking the Potential of Patient Navigation: New CPT Codes Pave the Way for Enhanced Oncology Care
November 20, 2024
Author: Sharita Howe, PharmD, Associate Director of Partner Development & Strategy The landscape of oncology care is evolving rapidly, driven by the need for more personalized, patient-centered approaches. In alignment with the Biden-Harris Cancer Moonshot initiative to provide equitable access to care, the Centers for Medicare & Medicaid Services (CMS) has introduced new CPT codes […]
read more
Pharmaceutical Famine
November 20, 2024
Author: Sharita Howe, PharmD, Associate Director of Partner Development & Strategy The oncology community faces a mounting crisis as essential chemotherapy drugs become alarmingly scarce across hospitals and clinics nationwide. This shortage gravely threatens cancer patients who rely on timely and effective chemotherapy, a crucial determinant of treatment success. For many patients, access to these […]
read more
Biosimilar Drama: Navigating Medicare’s Changing Landscape
October 30, 2024
Author: Natasha Olson, PharmD | Senior Manager of Clinical Communications & Outreach, NCODA The introduction of biosimilars and 505(b)(2) generics in oncology has been a game-changer for patients and practices alike. By offering cost-effective alternatives to high-priced branded biologics, these new treatments are poised to make cancer care more accessible and affordable. For the pharmaceutical […]
read more
Understanding Medicare’s 2025 Reforms: Key Impacts on Oncology Practices
October 30, 2024
Author: NCODA Editorial Team As we look ahead to 2025, significant changes to Medicare are set to bring much-needed relief to millions of Americans, particularly those facing the high costs of life-saving medications. With the introduction of a $2,000 out-of-pocket cap for prescription drugs under Medicare Part D and the new Medicare Prescription Payment Plan, […]
read more
NCODA Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation – Total Patient Management
October 16, 2024
If you’ve read the first two articles in our series about our recent posts on the NCODA CoE MIP Accreditation program, you know it promotes a fully integrated team approach to patient care, leveraging the electronic health record (EHR) at every stage of the patient journey. This ensures total patient management, including clinical assessments, lab […]
read more
NCODA Medically Integrated Pharmacy CoE Accreditation – Differentiation with a Commitment to Comprehensive Patient Onboarding
September 26, 2024
In this second article of our accreditation series, we highlight how NCODA’s Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) Accreditation standards actively support the comprehensive patient onboarding process, ensuring that each patient receives personalized and coordinated care from the very start of their treatment journey. NCODA CoE standards promote a comprehensive onboarding process, where […]
read more
Design of Limited Distribution Networks (LDNs)
September 24, 2024
Author: Sharita Howe, PharmD, Associate Director of Partner Development & Strategy The distribution of oncology and hematology medications is complex and highly regulated, involving multiple stakeholders such as manufacturers, distributors, pharmacies, and healthcare providers. One of the most critical aspects of specialty distribution is the use of Limited Distribution Networks (LDNs), which are networks utilized […]
read more
RESOURCES
Cost Avoidance Waste Tracker
Positive Quality Interventions
PQI in Action
OCE Sheets
IVE Sheets
Treatment Support Kits
PQI Podcast
Members
Member Resources
OPTA
Committees
Member Login
Events
Webinars
Spring Forum
Oncology Institute
PSO Annual Meeting
Fall Summit
contact@ncoda.org
315-655-4640
P.O. Box 468
Cazenovia, NY 13035
